THROMBOLYSIS

This adverse event was reported 222 times

These drugs are most commonly taken by patients reporting THROMBOLYSIS:

# Drug Count
0 ETONOGESTREL AND ETHINYL ESTRADIOL 45
1 ALTEPLASE 25
2 ASPIRIN 25
3 ASPIRIN 325 MG 24
4 ASPIRIN 81 MG 24
5 DABIGATRAN ETEXILATE 19
6 DABIGATRAN ETEXILATE MESYLATE 19
7 CLOPIDOGREL 13
8 FUROSEMIDE 10
9 RIVAROXABAN 10
See all common drugs associated with THROMBOLYSIS

THROMBOLYSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ERGOTAMINE TARTRATE AND CAFFEINE 2 0.0074
1 TENECTEPLASE 7 0.0044
2 ETONOGESTREL AND ETHINYL ESTRADIOL 45 0.0020
3 ELAGOLIX AND ESTRADIOL AND NORETHISTERONE 1 0.0017
4 ALTEPLASE 25 0.0017
5 VERICIGUAT 1 0.0010
6 CHLOROTHIAZIDE 1 0.0008
7 NIZATIDINE 1 0.0007
8 CAPLACIZUMAB 1 0.0006
9 ACETAMINOPHEN AND CODEINE PHOSPHATE 1 0.0005
See all drugs enriched for association with THROMBOLYSIS

THROMBOLYSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Calcitonin [EPC] 1 0.0003
1 Estrogen [EPC] 45 0.0002
2 Progestin [EPC] 45 0.0002
3 Anticholinergic [EPC] 2 0.0001
4 Cephalosporin Antibacterial [EPC] 1 0.0001
5 Thyroid Hormone Synthesis Inhibitor [EPC] 1 0.0001
6 Anti-anginal [EPC] 1 0.0001
7 Soluble Guanylate Cyclase Stimulator [EPC] 3 0.0001
8 Prostacyclin Receptor Agonist [EPC] 2 0.0001
9 Androgen [EPC] 2 0.0001
See all drug classes enriched for association with THROMBOLYSIS